Market Research Blog – Page 7019 – Just another WordPress site

Molybdenum Disilicide Market exhibit considerable growth at a CAGR of 7.2% in 2022 to 2032

Molybdenum disilicide is also known as Molybdenum Silicide is an inorganic compound having a tetragonal crystal structure, abbreviated as MoSi2. By appearance, Molybdenum disilicide is a grey metallic material and one of the finest pure material with significant shelf life.

Report Attribute	Key Statistics
Molybdenum Disilicide Market Estimated Base Year Value (2021)	US$ 3.8 Billion
Molybdenum Disilicide Market Expected Market Value (2022)	US$ 4.1 Billion
Molybdenum Disilicide Market Anticipated Forecast Value (2032)	US$ 8.5 Billion
Molybdenum Disilicide Market Projected Growth Rate (2022-2032)	7.2% CAGR

Molybdenum disilicide is insoluble in most of the acids except hydrofluoric and nitric acid. Key raw materials required in manufacturing of Molybdenum Disilicide include 99.9% molybdenum powder and 97% of pure silicon powder.  One of the prominent usage of molybdenum silicide is for fabrication of heating elements.

Moderate density and high melting point of 2030 deg. Celsius, make these compounds suitable for use in electric furnaces for production of glass and metals. The utilization of Molybdenum Disilicide in heating element helps to prevent the inner core of heating element from oxidation due to presence of passive layer of silicon, this can prevent the core even at very high temperature.

Another advantages of utilizing these compounds in heating element include stable electrical resistance and extended service life.

Market Dynamics: Molybdenum Disilicide Market

The use of Molybdenum Disilicide in refractory furnaces is considered to be a major driver for the market growth. Additionally, the use of molybdenum disilicide as a contact material in microelectronics is also aiding the growth of molybdenum disilicide market.

The preference of using molybdenum disilicide over substitute compounds such as Polysilicon due to very low hazardous effects and cost is also augmenting its consumption in the end use industries.  However, as molybdenum disilicide is in the initial stage of growth with its awareness of use at a limited extent, the growth of molybdenum disilicide market has been restrained on global scale.

For Critical Insights, Request for Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-8593

In spite of the current scenario, the subsequent growth of global molybdenum disilicide market is expected to gain traction in forthcoming years. The growth opportunities are also expected to offer from other end use industries such as food processing and pharmaceuticals for the global molybdenum disilicide market in the near future.

Regional Outlook: Molybdenum Disilicide Market

Molybdenum disilicide market is experiencing positive growth in the end use industry owing to, structural development, government initiative towards the manufacturing sector growth, etc. In terms of incremental $ opportunity, manufacturers from North America and Western Europe are estimated to represent a significant incremental $ opportunity in between forecast period.

On the basis of regional perspective, North America followed by Western Europe is estimated to be the key producer as well as consumer of molybdenum disilicide globally and is expected to witness for lucrative growth in the coming future owing to increasing demand from glass and ceramics industries in the region.

Developing countries in the Asia Pacific region, especially China and India, estimated to play substantial role in the growth of the molybdenum disilicide market during the forecast period owing to, increasing industrial activities, and accessibility of raw materials.

In terms of market volume share, more than two third of market volume is dominated by Asia Pacific region, especially from China, India and ASEAN countries. Middle East & Africa and Latin America region are expected to witness for moderate growth in the second half of forecast period as compared to first half.

Some of the key players of molybdenum disilicide market are the

I Squared R
American Elements

ZIRCAR
Kanthal
MHI
SCHUPP
Zhengzhou Chida

Shanghai Caixing
Yantai Torch

The research report presents a comprehensive assessment of the molybdenum disilicide market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. Molybdenum disilicide also contains projections using a suitable set of assumptions and methodologies. The molybdenum disilicide report provides analysis and information according to market segments such as geographies, application, and industry.

Ask Us Your Questions About This Report@ https://www.futuremarketinsights.com/ask-question/rep-gb-8593

The molybdenum disilicide report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with molybdenum disilicide market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Market Segmentation

Molybdenum Disilicide market is segmented on the basis of temperature grade, application, grades and end use

On the basis of temperature grade, molybdenum disilicide market segmented as

Up to 1700 Deg.

1700 Deg.–1900 Deg.
Above 1900 Deg.

On the basis of application, molybdenum disilicide market segmented as

Industrial
Laboratory

On the basis of grades, molybdenum disilicide market segmented as

Agriculture
Pharmaceutical
Technical

On the basis of end use industry, molybdenum disilicide market segmented as

Agriculture
Food Processing
Electronics
Steel
Glass

Ceramics
Pharmaceuticals

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

To be continued…!

Related Links:

https://pastelink.net/i4x95szy

https://www.fortunetelleroracle.com/news/chlorinated-polyethylene-market-size–share–demand-and-growth-analysis-by-2032-773881

https://www.atoallinks.com/2022/chlorinated-polyethylene-market-top-scenario-swot-analysis-forecast-2032/

About FMI

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
LinkedIn| Twitter| Blogs

With a steady CAGR of 6.1%, Concrete Admixture Market will reach US$ 27.4 Bn by 2032 – FMI

Notable rise in the use of concrete admixture in concrete formulations for the construction of industrial, residential, and commercial structures is anticipated to expand the concrete admixture market. The global concrete admixture market is expected to reach a value of US$ 15.1 Bn in 2022. With a steady CAGR of 6.1%, the market will reach US$ 27.4 Bn by 2032.

Attribute	Key Statistics
Global Concrete Admixture Market Estimated Size (2022E)	US$ 15.1 Bn
Projected Market Valuation (2032F)	US$ 27.4 Bn
Value-based CAGR (2022-2032)	6.1%
Collective Value Share: Top 3 Countries (2022E)	51%

Rising infrastructural needs of emerging economies, accelerated urbanization, and increasing government initiatives in the construction sector will push the construction market. This will culminate in a rise in the demand for concrete admixture.

Construction sites have high water requisites. Since it is difficult to have constant and easy access to water, water-reducing admixtures like plasticizers and superplasticizers are in high demand. Apart from removing water from concrete, plasticizers provide strength, durability, and a strong bridge between concrete and steel. Plasticizers also aid in reducing cracking, segregation, and bleeding which promotes growth. All these properties promote the growth of the market.

Get Sample of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-74

“High adoption rates of ready-mix concrete and precast concrete are likely to fuel demand for admixtures like superplasticizers. This will definitely boost growth in the concrete admixture market over the forecast period,” says an FMI analyst.

Key Takeaways:

Plasticizers and superplasticizers will dominate the concrete admixture market.
High demand for fast-setting concrete admixtures will propel market expansion.
India noted a rise in demand for liquid concrete admixture.
Concrete admixture market in India is predicted to exhibit a CAGR of 8.5%
Rapid expansion of the construction industry in China will boost the market possibilities for the Asia Pacific.
By application, residential segment will account for 62.3% market share during the forecast period.

Competitive Landscape

BASF SE, SIKA AG, GCP Applied Technologies, RPM International Inc., Fosroc International, Mapei S.P.A, CICO Technologies, CHRYSO S.A.S, Pidilite Industries Ltd, Rhein-Chemotechnik GmbH, Weber Saint-Gobain, Polisan Kimya San. A.S, Shandong Wanshan Chemical Co. Ltd., CEMEX SAB de CV, and others are some of the major players in the concrete admixture market that are profiled in the full version of the report.

In a competitive market, major players in the global concrete admixture market are focused on employing alternative distribution channels. These organizations are investing in research and development activities so as to innovate their existing product line and make it more eco-friendly.

Get Report Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-74

Concrete Admixture Market Outlook by Category

By Type:

Accelerating Admixture
Air Entraining Admixture
Retarding Admixture
Water Reducing Admixture
- Plasticizers
- Superplasticizers
Water Proofing Admixture
Others

By Application:

Residential
Infrastructure
Commercial
Industrial

https://reimagingmarketintellectualreports.wordpress.com/2022/11/11/chlorinated-polyethylene-market-size-share-demand-and-growth-analysis-by-2032/

https://www.tumblr.com/sanjay-chem/700576236706168832/chlorinated-polyethylene-market-size-share?source=share&_branch_match_id=948250511965936139&_branch_referrer=H4sIAAAAAAAAAwXByQ2AMAwEwIqMHzw4ujFhkQM5kGOEQvXMqPvdVmbxwZ%2B8JRtCzdyknNIpKDIHTdViEcdOd00drj2hgLLYBacWP1BTMfB74Fpsm%2BYJ4w8Tqz93WQAAAA%3D%3D

About FMI

Contact Us:

Surgical Monitors Market Insights on Latest Developments and Innovations Across the Industry

With 1000+ market research reports and 1 billion+ data points, Future Market Insights (FMI) serves each and every requirement of the clients operating in the global healthcare, pharmaceuticals, and medical device industries. FMI deploys digital intelligence solutions to offer compelling insights to report buyers that help them in overcoming market challenges, especially at the time of a crisis. Our dedicated team of professionals performs an extensive survey for gathering accurate information associated with the market.

Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-8118

FMI, in its upcoming business report, elaborates the historical and current scenario of the global Surgical Monitors market in terms of production, consumption, volume, and value. The report scrutinizes the market into various segments, regions and players on the basis of demand pattern and growth prospects.

Crucial information and forecast statistics covered in the Surgical Monitors market report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.

COVID-19 Impact Analysis on Surgical Monitors Market

The recent outbreak of the COVID-19 has turned the spotlight on the healthcare industry, and subsequently impacted the Surgical Monitors market. Severe shortages of critical medical supplies and a rapid rise in number of COVID-19 cases have resulted into a revolution rather than evolution in the healthcare ecosystems. Consequently, the impact is noticeable in the Surgical Monitors market.

Following government’s measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace.

The FMI’s report includes an interesting chapter on preliminary impact of the COVID-19 on the Surgical Monitors market. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge.

Why Choose Future Market Insights

Serving domestic and international clients 24/7
Prompt and efficient customer service
Data collected from reliable primary and secondary sources
Highly trained and experienced team of research analysts
Seamless delivery of tailor-made market research reports

Discounted prices for new customers! Offer expires soon!

Ask an Analyst@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-8118

Surgical Monitors Market: Segmentation

Valuable information covered in the FMI’s Surgical Monitors market report has been segregated into key segments and sub-segments.

Based on Screen Size, the global Surgical Monitors market is segmented as

<22.9”
23.0” – 26.9”
27.0” – 32.9”
33.0” – 41.9”
>42.0”

Based on Application, the global Surgical Monitors market is segmented as:

Endoscopy
Operating Room

Based on end user, the global Surgical Monitors market is segmented as:

Hospital
Ambulatory Surgical Center
Clinic

Surgical Monitors Market: Competition Analysis

The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Surgical Monitors market. Competitive information detailed in the Surgical Monitors market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Surgical Monitors market report.

Key players covered in the report include:

Skytron LLC, Barco, NDS Surgical Imaging, LLC Getinge Group, Sony Corporation, Steris Corporation, Berchtold Corporation and Stryker Corporation

Important Questions Answered in the Surgical Monitors Market Report

Which end user remains the top revenue contributor in different regional markets?
At what rate has the global Surgical Monitors market been expanding during the forecast period?
How will the global Surgical Monitors market look like by the end of the forecast period?
What innovative strategies are adopted by Surgical Monitors market players to stay ahead of the pack?
What are the restraints affecting the growth of the global Surgical Monitors market?

Buy Now@ https://www.futuremarketinsights.com/checkout/8118

Key Offerings of the Report

Growth Drivers and Opportunities: Comprehensive analysis on growth-driving factors and opportunities for market players in different regional markets
Recent Trends and Forecasts: Detailed assessment on the latest trends, technological developments, and forecasts for a 5-year or 10-year period.
Segmental Analysis: Extensive analysis on each segment and factors differentiating the role of these segments in market revenue forecasts and growth rate analysis
Regional Market Forecast: Thorough analysis of each regional market to arm stakeholders with necessary information to take critical decisions
Competitive Landscape: All-inclusive insights on both leading and emerging players vying for a slice of the Surgical Monitors market

About Future Market Insights (FMI)

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Recent Study Reveals Growth Prospects of Inflammatory Markers Market During 2022-2029

Inflammatory Markers Market structure analysis discusses in detail Inflammatory Industry companies with their profiles, revenue shares in market, comprehensive portfolio of their offerings, networking and distribution strategies, regional market footprints, and much more.

Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-10251

Global Inflammatory markers Market: Overview

Based on product type, inflammatory markers market has been segmented into interlukins, C reactive proteins, lepitine, cellular adhesion molecules, tumor necrosis factors and others. Interlukins are expected to hold a large revenue share in the global inflammatory markers market.

Based on the indications, the global inflammatory markers market has been segmented into tumors, arthritis, multiple sclerosis, diabetes and various other applications. Tumors are expected to hold a large revenue share in the overall inflammatory markers market.

Based on the end user, the inflammatory markers market has been segmented into hospitals, clinics, research laboratories and others. Research laboratories are expected to hold a significant share in the global inflammatory markers market.

Inflammatory Markers: Market Insights

Inflammatory markers are used in the assessment of cancer and other chronic diseases. Inflammation markers raise in the inflammatory conditions. C reactive protein and interleukin are the most common form of inflammatory markers.

Some of the common inflammatory conditions include rheumatoid arthritis, tissue injury and burns, Crohn’s disease, cancer, etc.

Introduction of an infectious organism including mycobacterium tuberculosis, protozoa, fungi, and other parasites that can resist host defenses and remain in the tissue for an extended period, is one of the major cause of chronic inflammation.

Other causes of chronic inflammation include exposure to a low level of particular irritant and foreign particles, autoimmune diseases, in which the immune system is sensitized. Chronic inflammation can be caused due to repeated episodes of acute inflammation.

Request for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-10251

Inflammatory markers: Market Dynamics

Increasing prevalence of cancer is one of the major factors, responsible for the significant growth of inflammatory markers market. Increasing population especially in developing regions and increasing prevalence of other chronic diseases, is expected to increase the growth of inflammatory markers market. Increasing research and developmental activities is another important factor which can drive the growth of inflammatory markers market.

Other factors such as increasing healthcare awareness, an increasing number of hospitals and research laboratories, etc. are expected to increase the growth of inflammatory markers market. Increasing government initiatives and increasing government funding for the research activities, is a very important factor which can increase the growth of inflammatory markers market.

An increasing number of diagnostic laboratories is expected to increase the growth of global inflammation markers market.

There are a few factors, which can restrain the growth of inflammatory markers market. Lack of healthcare awareness in some of the emerging regions is expected to increase the growth of the global inflammatory markers market.

Global Inflammatory markers Market: Region-wise Outlook

On the basis of geography, global inflammatory markers market is segmented into several key regions viz. North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East and Africa. North America is expected to hold the largest shares in the inflammatory markers market primarily due to presence of well-established healthcare infrastructure and the presence of large number of research laboratories Europe is expected to hold a large revenue share in Inflammatory markers market due to increasing population and increasing prevalence of chronic diseases.

Asian countries are also expected to hold a significant growth rate in the forecast period due to increasing healthcare awareness among the people.

Inflammatory markers Market: Key Players

There are many companies manufacturing inflammatory markers. Some of the key players present in Global Inflammatory markers market are Merck and Co., Novartis International AG, Abnova, Cayman Chemical, Thermo Fisher Scientific, Cell Signaling Technology, Inc., Boditech Med Inc., LSI Medience Corporation, Abbott Diagnostics Inc., Siemens Healthcare Diagnostics Inc., BG Medicine Inc., LifeSign LLC.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request for Report Ask A Question @ https://www.futuremarketinsights.com/ask-question/rep-gb-10251

Segmentation by Product Type

Interlukin
Interlukin 6
Interlukin 10
Others
C Reactive Protein
Lepitine
Cellular adhesion molecule
Tumor necrosis factor-α
Others

Segmentation by Indications

Tumors
Arthritis
Multiple Sclerosis
Diabetes
Other Applications

Segmentation by End Users

Hospitals
Diagnostic Laboratories
Research Laboratories
Others

About Future Market Insights (FMI)

Contact:

Microplate Washer Increasing Research and Development Projects to Spell Growth of the Market

Mass technological transformation of the global healthcare industry has left key market participants struggling to traverse the complexities of medical and life sciences. Given the shifting dynamics of the global healthcare sector, pharma and biotech companies are taking measured efforts to improve patient outcomes in an effective manner, while keeping a careful watch on the bottom line.

Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-7518

Much is being said about Artificial Intelligence taking over manual back office and supply chain operations in the healthcare ecosystem, threatening to replace physicians from critical claims processing roles. This might put pressure on pharmaceutical companies to ensure readiness to the new technology.

Big data and analytics will drive patient outcomes in a big way, and the coming years will witness a growing emphasis on healthcare service providers in the business of gathering and processing patient health data.

Creating outcome-oriented financial models to maximize reimbursements in value-based healthcare will be a strategic shift from the traditional fees-for-services model. This implies that pharmaceutical companies will need to devise appropriate measures to optimize costs and improve the quality of patient care.

The latest research report published by Future Market Insights on the Microplate Washer Market is intended to offer reliable data on various key factors shaping the growth curve of the market. This report works as a rich source of information for key entities such as policy makers, end-use industries, investors, and opinion leaders.

The research report published by Future Market Insights on the Microplate Washer Market provides a detailed overview of the demands and consumptions of various products/services associated with the growth dynamics of the market during the forecast period 2020 to 2030. The in-depth market estimation of various opportunities in the segments is expressed in volumes and revenues. The insights and analytics on the Microplate Washer market span several pages. These are covered in numerous sections, including, drivers and restraints, challenges and opportunities, regional segmentation and opportunity assessment, end-use/application prospects analysis, and competitive landscape assessment.

To remain ‘ahead’ of your competitors, Ask a Question >> https://www.futuremarketinsights.com/ask-question/rep-gb-7518

Regional Segments Analyzed Include:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, N. Africa)

The Report Covers Exhaustive Analysis On:

Market Segments
Market Dynamics
Market Size & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

What Do You Get in a Future Market Insights Study?

Factors affecting the overall development of the Microplate Washer Market
Factor that might restrain the growth of the global market in the coming years of the forecast period 2020 to 2030
What is present competitive scenario of the global Microplate Washer Market and its intricate details concerning potential business prospects of leading market players
Pricing strategies of several different market players in the Microplate Washer Market

What insights readers can gather from the Microplate Washer market report?

Learn the strategies, and modus operandi of every Microplate Washer market player –expansions, product launches, collaborations and acquisitions in the market currently
Enter the market with an objective view of of the progress outlook of the global Microplate Washer landscape, including total revenue, consumption and production, and historical & forecast
Get your hands on key drivers, opportunities, challenges to growth and trends (DROT Analysis)
Get a sneak-peek of trends, R&D developments, such as carbon footprint, prototype technologies, and globalization

To receive extensive list of important regions, ask for TOC here >> https://www.futuremarketinsights.com/toc/rep-gb-7518

The Microplate Washer Market report answers the following queries:

What is the largest share held by key players in the market?
What strategies have proven most advantageous in the Microplate Washer Market?
Which region promises largest opportunity for new investors during the forecast period 2020 to 2030?
What factors will most likely present challenges to growth during the forecast period?
What will be the value of total revenues, and at what CAGR will the growth compound during the forecast period?

Benefits of Future Market Insights Study

Future Market Insights has gradually established itself as one of the leading market research companies in the World. Our unique, methodical, and up-to-date approach towards creating high-quality market reports ensures the reports include relevant market insights. Further, our team of analysts leaves no stone unturned while curating market reports in accord with the requirement of our clients.

Why Choose Future Market Insights?

Deliver updated information on the current industry trends
Available 24/7 to facilitate clients with unbiased solutions
Embrace digital technologies to offer accurate business ideas
Exhaustive supply chain augmentation analysis
Provide reports strictly according to the requirements of the clients

About Future Market Insights (FMI)

Contact:

Molecular Imaging Market 2032 By Technology, Application, End User | Future Market Insights

Molecular imaging is an emerging diagnostic technology that allows visualization, differentiation, and quantify various biological processes occurring inside a living organism at the molecular and cellular level. The global Molecular Imaging Market is estimated to be valued approximately at US$ 4 Bn in 2021, finds Future Market Insights (FMI) in a study.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-724

Molecular imaging targets molecular pathways and mechanisms associated with a particular disease present inside a living body. It enables to study of the molecular abnormalities taking place inside the body to carry out early detection of disease and to optimize medications aiming for disease-related molecular targets. Nuclear medicine plays a vital role in conducting a molecular imaging process and can be broadly used for the treatment of distinct cancer and related diseases.

Clinical molecular imaging is trending towards hybrid modalities such as PET-CT, SPECT, or PET-MR that provide high-resolution anatomical imaging. PET-CT is anticipated to gain maximum revenue share over the forecast period, and the segment is projected to expand at a CAGR of 16.3% during the forecast period.

Molecular imaging has evolved as a promising tool for early detection of cancers and cardiac diseases, providing a more complete picture of the tumor genome, as well as monitoring tumor emergence during disease. Molecular imaging provides the ability to accurately evaluate biological responses to the treatment of individual patients over time, opening the door to personalized medical techniques directed by molecular imaging reporters.

Key Takeaways from Molecular Imaging Market Study

Molecular imaging market will register accelerating demand, enabling a y-o-y growth of nearly 11% in 2021
Backed by presence of a state-of-the-art healthcare infrastructure, the U.S. accounts for nearly 65% sales in North America
Driven by rising cases of cancer, the U.K. market will exhibit above 14% y-o-y growth in 2021
Government initiatives aimed at offering advanced medical care will enable growth in Germany and France
The market in China is expected to surge at a CAGR of over 10% from 2021 to 2031

“Increasing research & development activities in cancer-specific drug discovery and other chronic diseases are expected to boost demand for molecular imaging. Besides this, as a result of increasing incidence of cancer the demand for highly sensitive and precise diagnostic for better treatment solutions is increasing,” says a Future Market Insights analyst.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-724

Molecular Imaging Needs Rising In Response to Increasing Cancer CasesAccording to the World Health Organization (WHO) in 2020, breast cancer emerged as the most common type of cancer, affecting 2.2 million people around the world. Lung cancer has been the leading cause of death with over 1.7 Mn of total deaths in 2020. North America has the highest incidence rate of cancer followed by East Asia. This rise in the cancer population is leading to a rise in the demand for diagnostic imaging, thereby catalyzing the demand for molecular imaging.

Who is Winning?Key players in the molecular imaging market are keenly focusing on carrying out strategic activities such as acquisitions, collaborations, and mergers, product launch, global expansion to create a strong position in the market is leading to vigorous developments which are helping the market to grow at a considerable rate.

For instance, in 2019, Bruker Corporation launched a benchtop magnetic resonance spectrometer with a high-field 9.4 Tesla small animal MRI system with integrated in-line PET. Thus strengthening its product portfolio.

Strategies adopted by key players are often intended at global expansion. They largely focus on product launches and mergers & acquisitions. There have been a few strategic partnerships among leading players to enhance the product line and better facilities for end-user.

In September 2020, Bruker Corporation announced the acquisition of Canopy Biosciences, LLC. This acquisition enhances Bruker’s offering in targeted multi-omics and fluorescence-based imaging techniques.

Some of the key players are Key market players covered by Future Market Insights in the report are is Hermes Medical Solutions, Bruker Corporation, GE Company, Fujifilm Holdings Corp., Koninklijke Philips N.V., Siemens AG, Toshiba Medical System Corp., Mirada Medical Limited, Carestream Health, Inc., Esaote SpA, Positron Corporation, Medisco Ltd., Hitachi Medical Corp., MIM Software Inc.

Want more insights?Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global molecular imaging market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights based on a modality (Positron Emission Tomography (PET), Positron Emission Tomography- Computed Tomography (PET-CT), Positron Emission Tomography- Magnetic Resonance (PET-MR), Single Photon Emission Computed Tomography (SPECT), Software, Magnetic Resonance Spectroscopy, Molecular Ultrasound Imaging), Application (Cardiology, Oncology, Gastrointestinal Disorders, Neurology Disorders, Others) and end-user ( Hospitals, Ambulatory Surgical Centers, and Diagnostic Centers), across seven major regions of the world.

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/724

Molecular Imaging Market by CategoryModality

Positron Emission Tomography (PET)
Positron Emission Tomography- Computed Tomography (PET-CT)
Positron Emission Tomography- Magnetic Resonance (PET-MR)
Single Photon Emission Computed Tomography (SPECT)
Software
- On Premises Solutions
- Cloud Based Solutions
Magnetic Resonance
Molecular Ultrasound Imaging

Application

Cardiology
Oncology
Gastrointestinal Disorders
Neurology Disorders
Others

End User

Hospitals
- 500+ Beds
- 200-499 Beds
- Less than 200 Beds
Ambulatory Surgical Centres
Diagnostic Centres

About Future Market Insights (FMI)

Contact:

Global Market Study on Biopharmaceutical Contract Manufacturing Demand: Strong Pipeline to Rapidly Surge Growth

Reduced overall time to market investment in new drugs, access to expensive technologies, and greater flexibility are some advantages offered by biopharmaceutical manufacturing companies. On the back of these factors, several large companies have outsourced their biopharmaceutical manufacturing operations. Biopharmaceutical contract manufacturing is highly preferred among biopharmaceutical companies with limited in-house production capacity.

Get Sample PDF: https://www.futuremarketinsights.com/reports/sample/rep-gb-2982

Pharmaceutical companies mainly focus on core areas of competence, and hence, do not prefer to take financial risks in the event of formulating the final dose of medicines. This is anticipated to accelerate the growth of the global biopharmaceutical contract manufacturing market during forecast period, estimated to be valued at US$ 18.7 Bn by 2029.

List of Key Players Covered in Biopharmaceutical Contract Manufacturing market are:

Catalent Inc.
Lonza Group Ag
Patheon N.V. (Thermo Fisher Scientific Inc.)
Abzena Plc.
Sandoz International GmbH (Novartis AG)
Fujifilm Diosynth Biotechnologies (FUJIFILM Holdings)
Baxter Pharmaceutical Solutions LLC (Baxter Inc.)
AbbVie Contract Manufacturing (AbbVie Inc.)
Samsung Biologics Co. Ltd.
ProBioGen AG
Pfizer Centre Source Ltd (Pfizer Inc.)
Novasep
Biomeva GmbH
Kbi Biopharma Inc
Rentschler Biotechnologie GmbH
Ajinomoto Althea Inc. (Ajinomoto Co., Inc.)

“Asia Pacific is gaining attention among manufacturers for biologics production at reduced manufacturing cost. Emerging regions offering greater profit margins are major focus points for biopharmaceutical contract manufacturing, globally.”

Browse Detailed Summary of Research Report with TOC: https://www.futuremarketinsights.com/reports/biopharmaceutical-contract-manufacturing-market

Key Takeaways of Biopharmaceutical Contract Manufacturing Market Study

Although microbial-based platforms are abundantly used for the production of pharmaceuticals, mammalian-based cell culture is expected to gain traction during the forecast period, owing to higher efficiency and increasing demand.
In terms of product type, monoclonal antibodies currently hold a larger share of the biopharmaceutical contract manufacturing market, due to their superior efficacy as well as increasing adoption for the treatment of chronic diseases.
North America is anticipated to be the most lucrative region in the global biopharmaceutical contract manufacturing market, offering growth opportunities to market players.
The commercial application of biopharmaceutical contract manufacturing is expected to contribute a higher share as compared to clinical application by the end of 2029.

Order a Complete Research Report: https://www.futuremarketinsights.com/checkout/2982

Regional Insights

The U.S. dominates the North American region with a total market share of 91.0% in 2021 and is projected to continue experiencing high growth throughout the forecast period.

Germany is set to exhibit a CAGR of over 11.5% in the European biopharmaceutical contract manufacturing market during the forecast period. In this region, the next generation therapy market is believed to be driven by biological treatment options compared to the pharmaceutical option.

China holds 34.8% share in the East Asia market in 2021 and is projected to increase at a CAGR rate of 13.5% during the forecast period. The growth of the biopharmaceutical contract manufacturing market in the country is growing because, most of the pharma and biopharma companies are focusing to capitalize on the growth.

By Region:

North America
Latin America
Western Europe
Eastern Europe
APEJ
Japan
Middle East and Africa (MEA)

Detailed Table of Content:

Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. Analysis and Recommendations

Market Introduction

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

Market Background

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

3.3. Regulatory Overview

Global Biopharmaceutical Contract Manufacturing Market Analysis 2012-2021 and Opportunity Assessment, 2022-2029
Global Biopharmaceutical Contract Manufacturing Market Analysis 2012-2021 and Forecast 2022-2029, by Platform

TOC continued..!

Speak to our Research Expert: https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-2982

About Future Market Insights (FMI)

Contact:

Farm Animal Drugs Market – Global Analysis, Size, Share, Growth, Trends and Forecast 2022-2032

According to a latest study by Future Market Insights (FMI), the global Farm Animal Drug Market is projected to grow at over 6% CAGR during the period 2017-2027. Increased production of anti-infectives and penetration of parasiticides production in Latin America is expected to offer growth opportunities to players in this market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2402

The market will continue to be influenced by a slew of macro- and micro-economic factors. Demand for contamination-free meat and proteins and alliances between producers and meat companies will continue to offer growth opportunities.

North America Farm Animal Drugs Market

In North America, the U.S. will continue to be account for the leading revenue share. In 2017, the revenue share of the U.S. is anticipated to reach 58%; however, during the forecast period, it will lose slight market share to Canada. Demand for farm animal drugs in North America will continue to be influenced by growing consumption of fresh meat and regulation by the FDA to limit use of antibiotics on farm animals. FMI projects the North America farm animal drugs market to grow at 7% CAGR during the forecast period 2017-2027.

By product type, anti-infective drugs and parasiticides (endo-parasiticides, ecto-parasiticides, and endectocides). Anti-infectives are not only the largest but also the fastest-growing segment product type segment. By 2027, the anti-infective product type segment is projected to grow at nearly 9% CAGR. By animal type, poultry is the largest segment in North America, whereas ruminants and swine hold significant revenue share.

FMI also offers market forecast and analysis on the basis of route of administration. The oral route of administering drugs remains the most prominent in North America, with revenues projected to grow at over 7% CAGR. The parenteral drug segment, on the other hand, is anticipated to grow at nearly 9% CAGR through 2027.

By distribution channel, veterinary hospitals are the largest segment in North America, accounting for nearly US$ 2 billion in revenues in 2017. This segment is projected to grow at nearly 8% through 2027.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2402

Western Europe Farm Animal Drugs Market

U.K. remains the largest market for farm animal drugs in Western Europe. The country accounts for over 40% revenue share of the market. FMI projects U.K. to remain the largest market for farm animal drugs in Western Europe throughout the forecast period. Germany and France are the other leading markets for farm animal drugs in Western Europe. Overall, the Western Europe farm animal drugs market is projected to reach US$ 2.83 billion revenues in 2027.

The key factors fuelling demand for farm animal drugs in Western Europe include focus on preventive measures against zoonotic diseases. Use of certain drugs for pain management is also a growing opportunity for manufacturers. As is the case in North America, the anti-infective product type segment is projected to grow at over 6% CAGR through 2027.

In addition to North America and Western Europe, the report also offers market forecast and analysis on Asia Pacific excluding Japan, Middle East & Africa, Latin America, and Japan.

Competitive Landscape

Key companies profiled in the report are Bayer AG, Boehringer Ingelheim GmbH, Zoetis, Inc., Ceva Santé Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health (Sub. Eli Lilly), Merck Animal Health, Virbac SA, Vetoquinol SA, Intas Animal Health, Alembic Animal Health, Sequent Scientific, Hester Biosciences, Ashish Life Sciences, Ouro Fino Saude Animal (Ourofino), Zydus Animal Health (Sub. Cadila Healthcare Ltd), Phibro Animal Health Corporation, Nippon Zenyaku Kogyo Co., Ltd, Norbrook, Kyoritsu Seiyaku Corporation.

Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-2402

Market segmentation

A good market segmentation always covers the vitals in that particular market to arrive at important decisions. In the case of the farm animal drugs market, an all-inclusive research segmentation can be seen.

Product Type

Anti-Infective
Parasiticides
- Endo-parasiticides
- Ecto-parasiticides
- Endectocides
Anti-inflammatory
Anesthetics
Analgesics
Hormones and related products
Others

Animal Type

Livestock Animals
- Ruminants
- Swine
- Poultry
Equine

Route of Administration

Oral
Parenteral
Topical
Others

Distribution Channel

Veterinary Hospitals
Veterinary Clinics
Pharmacies and Drug Stores
Others

About Future Market Insights (FMI)

Contact:

Oral Controlled Release Drug Delivery Technology Market to reach a valuation of about US$ 68.4 Bn by the end of 2032

Future Market Insights (FMI), in its report, projects the Global Oral Controlled Release Drug Delivery Technology Market to register an impressive expansion at 7.2% CAGR during the forecast period 2017 to 2027.

Request Sample Copy of Report @

https://www.futuremarketinsights.com/reports/sample/rep-gb-4400

The market will surpass revenues worth US$ 20,000 Mn in 2017, and is further estimated to reach nearly US$ 50,000 Mn by 2027-end.

Oral Solid Dosage Manufacturers in North America Enabled to Achieve Significant Bioavailability

FMI’s report estimates North America to remain the largest market for oral controlled release drug delivery technology, with sales estimated to reach nearly US$ 20,000 Mn by 2027-end.

Being preferred route of drug administration by physicians, demand for oral controlled release drug delivery technology has been witnessing a surge by end-users in North America.

In addition, recent advancements in drug delivery have enabled oral solid dosage manufacturers in North America to achieve significant bioavailability through adoption of novel drug delivery platforms.

This is further expected to drive demand for oral controlled release drug delivery technology in the region.

However, increasing research activities related to biologic molecules, and their dominance in treating oncology conditions, coupled with government investments in these research activities are expected to impede the market growth in North America.

In addition, formulation challenges such as juncture of market expectations for once-daily dosing, and growth of controlled release tablets which impart abuse resistance, incurred in oral controlled release drug delivery technology are expected to further curb growth of the market in this region.

Request a Complete TOC of this Report with figures @ https://www.futuremarketinsights.com/toc/rep-gb-4400

New Chemical Entities Resulting from High Throughput Screening to Drive Market Growth in Western Europe

Western Europe will register the fastest expansion in the global oral controlled release drug delivery technology market.

This growth is primarily attributed to a slew of new chemical entities resulting from high throughput screening, which have low solubility and bioavailability.

This has further led manufacturers in this region to invest in drug delivery methods with better clinical outcome.

Owing to cost-sensitiveness in Western European countries, technologies enhancing bioavailability will remain preferred drug delivery system. These factors are expected to drive growth of the market in this region.

However, most of the pharmaceutical companies in Western Europe have complex supply chain, which is either under-utilised or inefficient.

Complexity of supply chain is attributed to low flexibility and cost-effectiveness. In addition, shortening of effective patent life along with patent cliffs is a major challenge for oral solid dosage forms in this region.

Factors such as these are estimated to hinder growth of the market in Western Europe.

Dissolution-Controlled Release System to Remain Sought-After among Drug Release Technologies in the Market

By drug release technology, dissolution-controlled release system will remain sought-after in the market, followed by diffusion-controlled release system.

Majority of generic formulations available are in tablet dosage form and follow dissolution-controlled release mechanism. Revenues from sales of dissolution-controlled release system will surpass US$ 10,000 Mn in 2017.

Demand for hydrodynamically-balanced drug delivery system will remain sluggish in the market.

Solid dosage forms of oral controlled release drug delivery technology are expected to remain dominant in the market, expanding at a high single-digit CAGR through 2027.

Sales of semisolid/liquid/suspensions dosage form segment will register a comparatively lower CAGR than that of solid dosage forms in the market through 2027.

Feel free to ask your queries @

https://www.futuremarketinsights.com/ask-question/rep-gb-4400

Key market players identified in FMI’s report include

AstraZeneca Plc.,

Bristol-Myers Squibb Company,

Sun Pharmaceuticals Industries Ltd,

Abbott Laboratories,

Merck & Co. Inc.,

Novartis AG,

Pfizer Inc.,

Mylan N.V.,

Sanofi,

Hoffman-La-Roche Ltd.,

Johnson & Johnson Services, Inc.,

Vectura Group plc.,

GlaxoSmithKline plc.

Market Taxonomy

By Region

North America

Latin America

Western Europe

Eastern Europe

APEJ

Japan

MEA

By Drug Release System

Diffusion Controlled Release System

Dissolution Controlled Release System

Osmotically Controlled Release System

Dissolution & Diffusion Controlled Release System

Ion Exchange Resins Controlled Release

Hydro-dynamically Balanced Drug Delivery System

Others

By Dosage Form

Solid Dosage Forms
Semisolid
Liquid/Suspension

Buy Now@ https://www.futuremarketinsights.com/checkout/4400

About Future Market Insights (FMI)

Contact:

Dengue vaccines Increasing Research and Development Projects to Spell Growth of the Market

Increasing prevalence of dengue fever throughout the Asia-Pacific region has propelled the demand for effectual medicines and vaccines to overcome this viral disease. While some pharmaceutical companies are focusing on development of a cure to dengue, the rate of dengue in Asia-Pacific region in expanding robustly. According a report published by Future Market Insights (FMI), Asia-Pacific region will dominate in the dengue vaccines market during the forecast period (2017-2027). The region is estimated to procure largest revenue share with expansion at 17.4% CAGR throughout the assessment period.

Get Sample of this Research Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1763

Geographic Overview

Latin America is likely to remain the second largest market for dengue vaccines and it will procure valuation nearly US$ 290 Mn by the end of forecast period. The report also forecasts that more and more pharmaceutical companies will be partaking in the expansion of dengue vaccines market in foreseeable period. A French drugmaker, Sanofi S.A. is actively participated in the market currently, while medicines are being formulated by leading players such as GlaxoSmithKline plc, Vabiotech, Merck & Co. Inc., Butantan Institute, Panacea Biotech Ltd, Takeda Pharmaceutical Company Limited, and Biological E. Limited.

The government institutes are expected to remain the largest end-user of the dengue vaccines, according to the report. Dengue vaccines sales across government institutes will generate revenues nearly US$ 650 Mn by the end of 2027. Further, hospitals will retain its dominance, exhibiting double-digit CAGR throughout the forecast period. Sales of the sole of the vaccines, Dengvaxia, manufactured by Sanofi is boosting the growth of the market presently. Additionally, the factors influencing the growth of the market profiled in the report are discussed below.

Key Highlights of Dengue Vaccines Market Report

Other than the burdening occurrence of dengue in some countries, the economic turmoil in Latin America is estimated to influence growth of the global market at macroeconomic level.
Live attenuated vaccines are also produced and developed economically, thereby consoling vaccines market and patients.
Low availability of optimum diagnostic systems and lack of skilled professionals have led to cases, where dengue fever is being treated as undistinguished febrile disease.
The global market of dengue vaccines is likely to secure an opportunistic revolution when companies are likely to able to successfully develop effective vaccines for all age groups.

Overall, the global dengue vaccines market, which is currently valued nearly US$ 250 Mn, will increase rapidly to reach over US$ 1,250 Mn in terms of revenues, by the end of 2027.

Buy this Research Report for Professional and Technical Industry Insights: https://www.futuremarketinsights.com/checkout/1763

About Future Market Insights (FMI)

Contact: